Syracuse NY 伯基特淋巴瘤临床试验
4项针对 伯基特淋巴瘤的研究正在 Syracuse及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- State University of New York Upstate Medical University, Syracuse
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
招募中2 期
- State University of New York Upstate Medical University, Syracuse
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- State University of New York Upstate Medical University, Syracuse
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
招募中3 期
- State University of New York Upstate Medical University, Syracuse
其他城市的 伯基特淋巴瘤试验
- Houston, TX21 项研究
- Philadelphia, PA16 项研究
- Milwaukee, WI16 项研究
- Chicago, IL15 项研究
- Cincinnati, OH13 项研究
- New York City, NY13 项研究
- Atlanta, GA12 项研究
- Aurora, CO11 项研究
- Seattle, WA11 项研究
- Durham, NC10 项研究
- Boston, MA10 项研究
- Kansas City, MO10 项研究
Syracuse的其他研究
- 非小细胞肺癌15 项研究
- 癌症（所有类型）9 项研究
- 前列腺癌9 项研究
- 非肌层浸润性膀胱癌8 项研究
- 卵巢癌7 项研究
- 子宫内膜癌7 项研究
- 肥胖症6 项研究
- 肺癌6 项研究
- 结直肠癌5 项研究
- 黄斑变性5 项研究
- 急性髓系白血病5 项研究
- 2型糖尿病5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。